Leishmania and human immunodeficiency virus coinfection: The first 10 years

Clinical Microbiology Reviews

Volumn 10, Issue 2, 1997, Pages 298-319

  Alvar, Jorge ^a   Cañavate, Carmen ^a   Gutiérrez Solar, Beatriz ^a   Jiménez, Maribel ^a   Laguna, Fernando ^a   López Vélez, Rogelio ^b   Molina, Ricardo ^a   Moreno, Javier ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTIMONY DERIVATIVE; GAMMA INTERFERON; ITRACONAZOLE; PAROMOMYCIN; PENTAMIDINE; STIBOGLUCONATE SODIUM;

CARDIOTOXICITY; CHILL; CLINICAL FEATURE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; LEISHMANIASIS; NEPHROTOXICITY; PANCREAS DISEASE; PATHOGENESIS; PHLEBITIS; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INSECTA; LEISHMANIA INFANTUM; NASO HEXACANTHUS; TRYPANOSOMATIDAE;

EID: 0030950966     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.10.2.298     Document Type: Review

References (304)

1. Addy, M., and A. Nandy. 1992. Ten years of kala-azar in West Bengal. I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24 Parganas? Bull. W. H. O. 70:341-346.
2. Adhya, S., M. Chatterjee, M. Q. Hassan, S. Mukherjee, and S. Sen. 1995. Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 89:622-624.
3. Adler, S., and O. Theodor. 1931. A study of the sandfly population in endemic foci of infantile kala-azar in Italy. Bull. Entomol. Res. 22:105-113.
4. Adler, S., and O. Theodor. 1935. Investigations on Mediterranean kala-azar. Proc. R. Soc. London Ser. B 116:505-515.
5. Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220-226.
6. Akuffo, H., M. Dietz, S. Teklemariam, T. Tadesse, G. Amare, and T. Yemane Berhan. 1990. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans. R. Soc. Trop. Med. Hyg. 84:532-534.
7. Alarcón, R., C. García, E. Daudén, A. Guerra, and F. Vanaclocha. 1987. Leishmaniasis cutánea postKala-azar en un paciente con inmunodeficiencia adquirida. Actas Dermo-Síf. 78:475-477.
8. Albrecht, H., H. J. Stellbrink, G. Gross, B. Berg, U. Helmchen, and H. Mensing. 1994. Treatment of atypical leishmaniasis with interferons-γ resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin. Invest. 72:1041-1047.
9. Altés, J., A. Salas, A. Llompart, and A. Obrador. 1991. Small intestinal involvement in visceral leishmaniasis. Am. J. Gastroenterol. 86:1283.
10. Altés, J., A. Salas, M. Riera, M. Udina, A. Galmés, J. Balanzat, A. Ballesteros, J. Buades, F. Salvá, and C. Villalonga. 1991. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 5:201-207.
11. Alvar, J. 1994. Leishmaniasis and Aids co-infection. the Spanish example. Parasitol. Today 10:160-163.
12. Alvar, J., and J. Blázquez. 1986. Leishmaniasis en procesos de inmunodeficiencia. Consideraciones sobre diez casos descritos procedantes de la cuenca mediterránea occidental. An. Med. Intern. (Madrid) 10:438-441.
13. Alvar, J., and M. I. Jiménez. 1994. Could infected drug-abusers act as potential L. (L.) infantum reservoirs? AIDS 8:854.
14. Alvar, J., B. Gutiérrez-Solar, R. Molina, R. López-Vélez, A. García-Camacho, P. Martínez, F. Laguna, E. Cercenado, and A. Galmés. 1992. Prevalence of Leishmania infection among AIDS patients. Lancet 339:1427.
15. Alvar, J., B. Gutiérrez-Solar, I. Pachón, E. Calbacho, M. Ramírez, R. Vallés, J. L. Guillén, C. Cañavate, and C. Amela. 1996. AIDS and Leishmania infantum: new approaches fur a new epidemiological problem. Clin. Dermatol. 14:241-246.
16. Alvar, J., J. Verdejo, A. Osuna, and R. Nájera. 1987. Visceral leishmaniasis in a patient seropositive for HIV. Eur. J. Clin. Microbiol. Infect. Dis. 6:604-606.
17. Andreo, J. A., F. Vivancos, P. Serrano, and J. Soriano. 1991. Leishmaniasis visceral con respuesta parcial al ketoconazol en un paciente con anticuerpos antivirus de la inmunodeficiencia humana. Med. Clin. 12:476-477.
18. Anonymous. 1994. Registro Nacional de SIDA. Vigilancia del SIDA en España: informe trimestral no. 4. Centro Nacional de Epidemiología, Madrid, Spain.
19. Antezana, G., R. Zeballos, C. Mendoza, P. Lyevre, L. Valda, F. Cárdenas, I. Noriega, H. Ugarte, and J. P. Dedet. 1992. Electrocardiographs alteractions during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol. Trans. R. Soc. Trop. Med. Hyg. 86:31-33.
20. Antunes, F., C. Carvalho, L. Tavares, J. Botas, M. Forte, A. M. Rio, L. Dutschmann, A. Costa, P. Abranches, C. Silva Pereira, J. E. D. Pavia, F. Carvalho Araujo, and A. Baptista. 1987. Visceral leishmaniasis recrudescence in a patient with AIDS. Trans. R. Soc. Trop. Med. Hyg. 81:595.
21. Aragort de Rossell, R., R. J. de Durán, O. Rossel, and A. M. Rodríguez. 1992. Is leishmaniasis ever cured? Trans. R. Soc. Trop. Med. Hyg. 86:251-253.
22. Badaró, R., E. M. Carvalho, H. Rocha, A. C. Queiroz, and T. C. Jones. 1986. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet ii:647-648.
23. Badaró, R., T. C. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed, A. Barral, R. Teixeira, and W. D. Johnson, Jr. 1986. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1003-1011.
24. Badaró, R., and W. D. Johnson. 1993. The role of interferon-γ in the treatment of visceral and diffuse cutaneous leishmaniasis. J. Infect. Dis. 167(Suppl. 1):S13-S17.
25. Balslev, U., F. Jonsbo, J. Junge, and K. D. Bentsen. 1991. Tre tilfaelde af visceral leishmaniasis: det ene ho en HIV-positiv mand. Ugeskr.-Laeg. 153:1591-1592.
26. Barberá, J. R., J. A. Capdevilla, M. J. Fontova, and I. Ocaña. 1994. Leishmaniasis oral en un paciente con el virus de la inmunodeficiencia humana. Med Gin (Barcelona) 103:477.
27. Barcellini, W., G. P. Rizzardi, M. O. Borghi, C. Fain, A. Lazzarin, and P. L. Meroni. 1994. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8:757-762.
28. Barrio, J., M. Lecona, J. Cosin, F. J., Olalquiaga, J. M. Hernanz, and J. Soto. 1996. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient. Br. J. Dermatol. 134:164-166.
29. Belazzoug, S., G. Lanotte, R. Maazoun, F. Pratlong, and J. A. Rioux. 1985. Un nouveau variant enzymatique de Leishmania infantum Nicolle, 1908, agent de la leishmaniose cutanée du nord de l'Algérie. Ann. Parasitol. Hum. Comp. 60:1-3.
30. Belda Mira, A., F. Díaz Sánchez, B. Martínez García, E. Gonzalvo Bellver, V. Antón Crespo, and J. Redón Más. 1994. Leishmaniasis visceral y SIDA. A propósito de dos casos con diseminación cutánea. An. Med. Intern. (Madrid) 8:398-400.
31. Berenguer, J., S. Moreno, E. Cercenado, J. C. L. Bernaldo de Quirós, A. García de la Fuente, and E. Bouza. 1989. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann. Intern. Med. 111:129-132.
32. Berhe N., A. Hailu, and T. Gemetchu. 1995. Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to L. aethiopica. Trans. R. Soc. Trop. Med. Hyg. 89:400-401.
33. Berhe, N., A. Hailu, D. Wolday, Y. Negesse, P. Cenini, and D. Frommel. 1995. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans. R. Soc. Trop. Med. Hyg. 89:205-207.
34. Bernard, E., S. Dodot, J. F. Michiels, S. Politano, Y. Le Fichoux, and P. Dellamonica. 1988. Leishmaniose viscérale au cours du syndrome immunodéficitaire acquis. Presse Med. 17:872.
35. Bernier, R. S. J. Turco, M. Olivier, and M. Tremblay. 1995. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J. Virol. 69:7282-7285.
36. Bettini, S., M. Gramiccia, L. Gradoni, P. Biggio, R. Loi, F. Cottoni, M. Pau, and M. C. Atzeni. 1990. Leishmaniasis in Sardinia. IV. Epidemiological appraisal of cutaneous leishmaniasis and biochemical characterization of isolates. J. Trop. Med. Hyg. 93:262-269.
37. Bettini, S., M. Gramiccia, L. Gradoni, E. Pozio, S. Mugnal, and M. Maroli. 1983. Leishmaniasis in Tuscany (Italy). VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann. Parasitol. Hum. Comp. 58:539-547.
38. Biggar, R. J., J. J. Goedert, and J. Hoofnagle. 1987. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N. Engl. J. Med. 316:630-631.
39. Bissuel, F., C. Leport, C. Perronne, P. Longuet, and J. L. Vilde. 1994. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J. Intern. Med. 236:529-35.
40. Borelli, D. 1987. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev. Infect. Dis. 9(Suppl. 1):S57-S63.
41. Borthwick, N. J., M. Bofill, W. M. Gombert, A. N. Akbar, E. Medina, K. Sagawa, M. V. Lipman, M. A. Johnson, and G. Janossy. 1994. Lymphocyte activation in HIV-infection. Functional defects of CD28-T cells. AIDS 8:431-441.
42. Borzoni, F., L. Gradoni, M. Gramiccia, A. Maccioni, E. Valdes, and S. Loddo. 1991. A case of lingual and palatine localization of a viscerotropic Leishmania infantum zymodeme in Sardinia, Italy. Trop. Med. Parasitol. 42:193-194.
43. Botet, J., and M. Portús. 1993. La leishmaniosis en la España peninsular. Revisión histórico-bibliográfica (1912-1985). Rev. Sanid. Hig. Pública 67: 255-266.
44. Broeckaert-van Orshoven, A., P. Michielsen, and J. Vandepitte. 1979. Fatal leishmaniasis in renal-transplant patient. Lancet ii:740-741.
45. Burns, J. M., Jr., W. G. Shreffler, D. R. Benson, H. W. Ghalib, R. Badaró, and S. G. Reed. 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90:775-779.
46. Cabié, A., S. Matheron, A. Lepretre, O. Bouchaud, A. M. Deloul, and J. P. Coulaud. 1992. Leishmaniose viscérale au course de l'infection par le VIH. Une infection opportuniste a part entiere. Presse Méd. 21:1658-1662.
47. Cacopardo, B., L. Nigro, W. Preiser, A. Fama, M. I. Satariano, J. Braner, B. M. Celesia, B. Weber, R. Russo, and H. W. Doerr. 1996. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans. R. Soc. Trop. Med. Hyg. 90:434-435.
48. Campino, L., G. Santos-Gomes, F. Pratlong, J. P. Dedet, and P. Abranches. 1994. HIV-Leishmania co-infection in Portugal: isolation of Leishmania infantum MON-24. Trans. R. Soc. Trop. Med. Hyg. 88:394.
49. Cánovas, D. L., J. Carbonell, J. Torres, J. Altés, and J. Buades. 1994. Laryngeal leishmaniasis as initial opportunistic disease in HIV infection. J. Laryngol. Otol. 108:1089-92.
50. Carbonell, J., D. L. Cánovas, R. Solee, and S. Más. 1995. Leishmaniasis en ORL. An. Otorrinolarinol. Ibero-Am. 22:139-149.
51. Cardeñosa, N., C. Riera, P. Cortés, F. March, C. Muñoz, M. Portús, and G. Prats. 1995. Detection and characterization by immunoblot analysis of potentially diagnostic Leishmania infantum polypeptides in human visceral leishmaniasis. Parasite Immunol. 17:509-516.
52. Casares Mateos, E. 1961. Contribución al estudio del foco de leishmaniosis canina, de Madrid. Rev. Sanit. Hig. Pública 35:241-250.
53. Cenini, P., N. Berhe, A. Hailu, and D. Frommel. 1994. Mononuclear cell subpopulations in human immunodeficiency virus(HIV)-positive versus HIV-negative patients with visceral leishmaniasis. J. Infect. Dis. 169:707-708.
54. Centers for Disease Control. 1992. Viscerotropic leishmaniasis in persons returning from operation Desert Storm 1990-1991. Morbid. Mortal. Weekly Rep. 41:131-134.
55. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
56. Chenoweth, C. E., S. Singal, R. D. Pearson, R. F. Betts, and D. M. Markovitz. 1993. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest 103:648-649.
57. Chulay, J. D., and A. D. M. Bryceson. 1983. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32:475-479.
58. Chulay, J. D., M. A. Adoyo, and J. I. Githure. 1985. Leishmania donovani parasitemia in Kenyan visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 79:218-222.
59. Chunge, C. N., G. Gachihi, R. Muigai, K. Wasunna, J. R. Rashid, J. D. Chulay, G. Anabwani, C. N. Oster, and A. D. M. Bryceson. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans. R. Soc. Trop. Med. Hyg. 79:715-718.
60. Chunge, C. N., J. Owate, H. O. Pamba, and L. Donno. 1990. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans. R. Soc. Trop. Med. Hyg. 79:221-225.
61. Clark, T. B., W. R. Kellen, J. E. Lindegren, and T. A. Smith. 1964. The transmission of Crithidia fasciculata Léger 1902 in Culiseta incidens (Thomson). J. Protozool. 11:400-402.
62. Clerici, M., and G. M. Shearer. 1993. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
63. Cnudde, F., C. Raccurt, F. Boulard, B. Teron-Aboud, M. Nicolas, and B. Juminer. 1994. Diffuse cutaneous leishmanisis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. AIDS 8:559-860.
64. Cohen, C., F. Corazza, P. De-Mol, and D. Brasseur. 1991. Leishmaniasis acquired in Belgium. Lancet 338:128.
65. Colmenares, M., M. Portús, C. Riera, M. Gállego, M. J. Aisa, S. Torrás, and C. Muñoz. 1995. Detection of 72-75 KD and 123 KD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 52:427-428.
66. Condom, M. A., B. Clotet, G. Sirera, F. Milla, and M. Foz. 1989. Asymptomatic leishmaniasis in the acquired immunodefieciency Sindrome (AIDS). Ann. Intern. Med. 111:767-768.
67. Coutinho, S. G., A. M. Da-Cruz, M. Pereira de Oliveira, S. C. F. Mendonça, A. L. Bertho, and P. M. De Luca. 1996. CD4+ and CD8+ T cell immune responses of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis. Mem. Inst. Oswaldo Cruz Rio J. 91:381-384.
68. Cozon, G., T. Grenland, and J. P. Revillard. 1990. Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis. Lancet 322:132.
69. Cunha, R. M. C., K. A. Hallack, and M. C. M. N. Castanon. 1991. Leishmaniose tegumentar difusa em paciente infectado pelo HIV: relato de um caso. Rev. S. Brasil. Med. Trop. 24(Suppl. 2): 109-110.
70. + T cells associated with cure of human cutaneous leishmaniasis. Infect. Immun. 62:2614-2618.
71. Da-Cruz, A. M., E. S. Machado, J. A., Menezes, M. S. Rutowitsch, and S. G. Coutinho. 1992. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans. R. Soc. Trop. Med. Hyg. 86:511-512.
72. Datry, A., T. Similowski, P. Jais, M. Rosenheim, C. Katlama, E. Maheu, S. Kuaz, D. Fassin, M. Danis, and M. Gentilini. 1990. AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation. Trans. R. Soc. Trop. Med. Hyg. 84:239-240.
73. Daudén, E., P. F. Peñas, L. Ríos, M.I. Jiménez, J. Fraga, J. Alvar, and A. García-Díez. 1996. Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS. J. Am. Acad. Dermatol. 35:316-319.
74. Davidson, R. N., L. Di Martino, L. Gradoni, R. Giacchino, R. Russo, G. B. Gaeta, R. Pempinello, S. Scott, F. Raimondi, A. Cascio, T. Prestileo, L. Caldeira, R. J. Wilkinson, and A. D. M. Bryceson. 1994. Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis: a multicentre trial. Q. J. Med. 87:75-81.
75. Davidson, R. N., and R. Russo. 1994. Relapse of visceral leishmaniasis in patients who were coinfected with human immnunodeficiency virus and who received treatment with liposomal amphotericin B. Clin. Infect. Dis. 19:560.
76. De Bruijn, M. H. L., and D. C. Barker. 1992. Diagnosis of new World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop. 52:45-58.
77. De Bruijn, M. H. L., L. A. Labrada, A. J. Smyth, C. Santrich, and D. C. Barker. 1993. A comparative study of diagnosis by the polymerase chain reaction and by current clinical methods using biopsies from Colombian patients with suspcted leishmaniasis. Trop. Med. Parasitol. 44:201-207.
78. Dedet, J.-P., M. Lambert, and F. Pratlong. 1995. Leishmanioses et infection par le virus de l'immunodéficience humaine. Presse Med. 24:1036-1040.
79. Dedet, J.-P., R. Roche, F. Pratlong, D. Cales-Quist, J. Jouannelle, J. C. Benichou, and M. Huerre. 1995. Diffuse cutaneous infection caused by a presumed monoxenous trypanosomatid in a patient with HIV. Trans. R. Soc. Trop. Med. Hyg. 87:644-646.
80. De la Loma, A., J. Alvar, E. Martínez, J. Blázquez, A. Alcalá, and R. Nájera. 1985. Leishmaniasis or AIDS? Trans. R. Soc. Trop. Med. Hyg. 79:421-422.
81. Dellamonica, P., E. Bernard, Y. Le Fichoux, S. Politano, M. Carles, J. Durand, and V. Mondain. 1989. Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J. Infect. Dis. 160:904-905.
82. Dereure, J., J. Reynes, F. Pratlong, I. Lamaury, J. A. Rioux, F. Janbon, and J.-P. Dedet. 1995. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull. W. H. O. 73:245-246.
83. Desjeux, P. 1991. Information on the epidemiology and control of the leishmaniases by country and territory. Report no. 27. World Health Organization, Geneva, Switzerland.
84. Desjeux, P. 1992. Human leishmaniases: epidemiology and public health aspects. World Health. Stat. Q. 45:267-275.
85. Dietze, R., E. P. Milan, J. D. Berman, M. Grögl, A. Falqueto, T. F. Feitosa, K. G. Luz, F. A. Suassuna, L. A. Marinho, and G. Ksionski. 1993. Treatment of Brazilian kala-azar with a short course of Ampocil (amphotericin colesterol dispersion). Din. Infect. Dis. 17:981-986.
86. Duarte, M. I. S., V. L. R. Da Mata, C. E. P. Corbbett, M. D. Laurenti, R. Chebabo, and H. Goto. 1992. Interstitial neumonitis in human visceral leishmaniasis. AIDS 6:238-240.
87. Easterbrook, M. D., M. H. Levy, A. M. Gómez, S. T. Turco, R. M. Epand, and K. L. Rosenthal. 1995. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania, J. Acquired Immun. Defic. Syndr. Hum. Retrovirol. 10:496-505.
88. Echevarría, J., P. Campos, J. Chang, L. Cuéllar, E. Gotuzzo, L. Paz, and A. Llanos-Cuentas. 1993. Mucocutaneous leishmaniasis and AIDS: case report. Trans. R. Soc. Trop. Med. Hyg. 87:186.
89. El-Hassan, A. M., E. E. Zijlstra, S. E. O. Meredith, H. W. Ghalib, and A. Ismail. 1993. Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the Sudan. Acta Trop. 55:87-90.
90. El-Safi, S. H., W. Peters, and D. A. Evans. 1991. Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 85:465-470.
91. Eresh, S., S. M. McCallum, and D. C. Barker. 1994. Identification and diagnosis of Leishmania mexicana complex isolates by polymerase chain reaction. Parasitology 109:423-433.
92. España, A., J. M. Hermida, P. Montilla, and L. Buzón. 1990. Leishmaniasis cutánea y sistémica con infección por virus herpes en un paciente con SIDA. Rev. Clin. Esp. 187:437.
93. Fernández-Guerrero, M. L., J. M. Aguado, L. Buzón, C. Barros, C. Montalbán, T. Martín, and E. Bouza. 1987. Visceral leishmaniasis in immunocompromised hosts. Am. J. Med. 83:1098-1102.
94. Fillola, G., J. X. Corberand, P. F. Laharrague, H. Levenes, P. Massip, and P. Recco. 1992. Peripheral intramonocytic leishmaniasis in an AIDS patient. J. Clin. Microbiol. 30:3284-3285.
95. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauct. 1989. Tumor necrosis factor alpha induces expression of human inmunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
96. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238:800-802.
97. Franco-Vicario, R., J. M. Beltrán de Heredia, P. Rojo, and C. Hermosa. 1987. Leishmaniosis asociada al síndrome de la inmunodeficiencia adquirida. Med. Clin. 88:565-566.
98. Gachihi, G. S., J. B. O. Were, P. E. Coyne, R. K. Muigai, P. M. Nyakundi, K. M. A. Wasunna, and J. A. Sherwood. 1992. A prospective randomized trial of sodium stibogluconate alone versus sodium stibogluconate plus allopurinol in the treatment of visceral leishmaniasis in Kenya, abstr. TuP8-4. In Proceeding of the XIIIth International Congress for Tropical Medicine and Malaria.
99. Gachihi, G. S., J. B. O. Were, R. K. Muigai, J. A. Sherwood, Z. S. Mbugua, and G. Karigi. 1992. A short course high dose sodium stibogluconate (Pentostam) in treatment of visceral leishmaniasis in Kenya, abstr. WeO1-4. In Proceeding of the XIIIth International Congress for Tropical Medicine and Malaria.
100. Gállego, J., R. Fisa, J. A. Rioux, F. Pratlong, E. Guilvard, J. Gállego, C. Riera, T. Juncosa, and M. Portús. 1993. Los zimodemas de Leishmania infantum en la comarca del Priorato. Acta Parasitol. Port. 1:49.
101. Galvao-Castro, B., J. A. Saferreira, K. F. Marzochi, M. C. Marzochi, S. G. Coutinho, and P. H. Lambert. 1984. Polyclonal B-cell activation, circulating immune complexes and autoimmunity in human visceral leishmaniasis. Clin. Exp. Immunol. 56:58-66.
102. García, M., R. M. de Andrés, T. Santillana, and B. Orejas. 1994. Leishmaniasis visceral con afectación intestinal en paciente con sida. Enferm. Infect. Microbiol. Clin. 12:415-416.
103. Gari-Toussaint, M., A. Leliévre, P. Marty, and Y. Le Fichoux. 1994. Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus. Trans. R. Soc. Trop. Med. Hyg. 88:301-302.
104. Gasser, R. A., A. J. Magill, C. N. Oster, E. D. Franke, M. Grögl, and J. D. Berman. 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin. Infect. Dis. 18:83-90.
105. Gazapo, E., F. Laguna, P. Martínez, M. Adrados, M. L. Martínez, and F. Díaz. 1992. Visceral leishmaniasis secondary prophylaxis in HIV patients, abstr. TuP8-13. In Proceedings of the VIIth International Conference on AIDS.
106. Gillis, D., S. Klaus, L. F. Schnur, P. Piscopos, S. Maayan, E. Okon, and D. Engelhard. 1995. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Pediatr. Infect. Dis. J. 14:247-249.
107. Githure, J. L., L. D. Hendricks, L. F. Schmur, G. Kilu, and P. V. Perkins. 1986. Characterization of Crithidia-like organism isolated from man, animals and sand flies in leishmaniasis endemic foci in Kenya, p. 243-247. In Proceedings of the Seventh Annual Medical Scientific Conference. KEMRI/KETRI, Nairobi, Kenya.
108. Golino, A., J. M. Duncan, B. Zeluff, J. De Priest, H. A. McAllister, B. Radovancevic, and O. H. Frazier. 1991. Leishmaniasis in a Heart transplant patient. J. Heart Lung Transplant. 11:820-823.
109. González-Anglada, M. I., J. M. Peña, F. J. Barbado, J. J. González, C. Redondo, C. Galera, M. Nistal, and J. J. Vázquez. 1994. Two cases of laryngeal leishmaniasis in patients infected with HIV. Eur. J. Clin. Microbiol. Infect. Dis. 13:509-511.
110. Górgolas, M., J. M. Castrillo, and M. L. Fernádez-Guerrero. 1994. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavelent antimony and interferon-γ. Clin. Infect. Dis. 17:56-58.
111. Górgolas, M., and M. A. Miles. 1994. Visceral leishmaniasis and AIDS. Nature 372:734.
112. Gradoni, L., and M. Gramiccia. 1994. Leishmania infantum tropism: strain genotype or host immune status? Parasitol. Today 10:264-267.
113. Gradoni, L., M. Gramiccia. and F. Betti. 1990. Fatal visceral disease caused by a dermotropic Leishmania in a patient with human immunodeficiency virus infection. J. Infect. 20:169-184.
114. Gradoni, L., M. Gramiccia, N. Léger, B. Pesson, G. Madulo-Leblond, R. Killick-Kendrick, M. Killick-Kendrick, and B. C. Walton. 1991. Isoenzyme characterization of Leishmania from man, dog and sandflies in the Maltese islands. Trans. R. Soc. Trop. Med. Hyg. 85:217-219.
115. Gradoni, L., G. Guaraldi, M. Codeluppi, A. Scalone, and F. Rivas. 1995. Gastric localization of Leishmania in a patient with acquired immunodeficiency syndrome. APMIS 103:25-28.
116. Gradoni, L., A. Scalone, and M. Gramiccia. 1993. HIV-Leishmania co-infections in Italy: serological data as indication of the sequence of acquisition of the two infections. Trans. R. Soc. Trop. Med. Hyg. 87:94-96.
117. Gramiccia, M., R. Ben-Ismail, L. Gradoni, M. S. Ben Rachid, and M. A. Ben Said. 1991. Leishmania infantum enzymatic variant, causative agent of cutaneous leishmaniasis in north Tunisia. Trans. R. Soc. Trop. Med. Hyg. 85:370-371.
118. Gramiccia, M., S. Bettini, L. Gradoni, P. Ciarmoli, M. L. Verrilli, S. Loddo, and C. Cicalò. 1990. Leishmaniasis in Sardinia. 5. Leishmanin reaction in the human population of a focus of low endemicity of canine leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:371-374.
119. Gramiccia, M., L. Gradoni, L. Di Martine, R. Romano, and D. Ercolini. 1992. Two syntopic zymodemes of Leishmania infantum cause human and canine visceral leishmaniasis in the Naples area, Italy. Acta Trop. 50:357-359.
120. Gramiccia, M., L. Gradoni, and E. Pozio. 1986. Caractérization biochimique de souches du complexe Leishmania infantum isolées en Italie, p. 445-454. In J. A. Rioux (ed.), Leishmania, taxonomie et phylogenèse. Applications éco-épidemiologiques. IMEEE, Montpellier, France.
121. Gramiccia, M., L. Gradoni, and M. Troiani. 1992. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. Hyg. 86: 161-163.
122. Gramiccia, M., L. Gradoni, and M. Troiani. 1995. Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in south Italy. FEMS Microbiol. Lett. 128:33-38.
123. Grau, J. M., X. Bosch, A. C. Salgado, and A. Urbano-Márquez. 1989. Human immunodeficiency virus (HIV) and aplastic anemia. Ann. Intern. Med. 110:576-577.
124. Graziosi, C., G. Pantaleo, K. R. Gantt, J.-P. Fortin, J. F. Demarest, O. J. Cohen, P. S. Rafick, and A. S. Fauci. 1994. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248-252.
125. Grögl, M., J. L. Daugirda, D. L. Hover, A. J. Magill, and J. D. Berman. 1993. Survivality and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions. Am. J. Trop. Med. Hyg. 49:308-315.
126. Grögl, M., T. N. Thomason, and E. D. Franke. 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47:117-126.
127. Guarino, A., A. Castaldo, L. Di Martino, A. Rubino, G. B. Gaeta, and L. Gradoni. 1994. Visceral leishmaniasis in a child with HIV-1 infection. Eur. J. Pediatr. 153:301-302.
128. Guevara, P., J. L. Ramírez, E. Rojas, J. V. Scorza, N. González, and N. Añez. 1993. Leishmania braziliensis in blood 30 years after cure. Lancet 341:1341.
129. Gutiérrez-Macias, A., J. J. Alonso-Alonso, and C. Aguirre-Errasti. 1995. Esophagcal leishmaniasis in a patient infected with the human immunodeficiency virus. Clin. Infect. Dis. 21:229-230.
130. Haldar, J. P., S. Ghose, K. C. Saha, and A. C. Ghose. 1983. Cell-mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis. Infect. Immun. 42:702-707.
131. Hernández, D., N. Rodríguez, C. Martínez, L. García, and J. Convit. 1993. Leishmania braziliensis causing visceral leishmaniais in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 87:627-628.
132. Hernández, D. E., M. Oliver, C. Martínez, and G. Planas. 1995. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in AIDS. Int. J. Dermatol. 34:114-115.
133. Hernández, D. E., N. Rodríguez, M. Wessolossky, and J. Convit. 1995. Visceral leishmaniais due to a Leishmania variant that shares kinetoplast DNA sequences with Leishmania braziliensis and Leishmania mexicana in a patient infected with human immunodeficiency virus: identification of the Leishmania species with the use of the polymerase chain reaction. Clin. Infect. Dis. 21:701-702.
134. Herwaldt, B. L., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46:296-306.
135. Heudier, P., B. Taillan, G. Garnier, P. Marty, J. G. Fuzibet, and P. Dujardin. 1993. Localisation pulmonaire d'une leishmaniose viscerale au cours de l'infection par le VIH. Presse Med. 22:1060.
136. Jeannel, D., P. Tuppin, G. Brucker, M. Danis, and M. Gentilini. 1991. Imported and autochthonous kala-azar in France. Br. Med. J. 303:336-338.
137. Jha, T. K. 1983. Evaluation of allopurinol in the treatment of kala-azar ocurring in North Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 77:204-207.
138. Jiménez, M. I. Unpublished data.
139. Jiménez, M. I., M. Ferrer-Dufol, C. Cañavate, B. Gutiérrez-Solar, R. Molina, F. Laguna, R. López-Vélez, E. Cercenado, E. Daudén, J. Blázquez, C. Ladrón de Guevara, J. Gómez, J. de la Torre, C. Barros, J. Altés, T. Serra, and J. Alvar. 1995. Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol. Lett. 131:197-204.
140. Jiménez, M. I., B. Gutiérrez-Solar, A. Benito, A. Aguiar, E. García, E. Cercenado, and J. Alvar. 1991. Cutaneous Leishmania (L.) infantum zymodemes isolated from bone marrow in AIDS patients. Res. Rev. Parasitol. 51:95-99.
141. Jiménez, M. I., F. Laguna, J. de la Torre, F. Solís, and J. Alvar. 1995. New Leishmania (Leishmania) infantum zymodemes responsible for visceral leishmaniais in HIV-positive co-infected patients from Spain. Trans. R. Soc. Trop. Med. Hyg. 89:33.
142. Jiménez, M. I., R. López-Vélez, R. Molina, C. Cañavate, and J. Alvar. 1996. HIV co-infection with a currently non-pathogenic flagellate. Lancet 347: 246-247.
143. Kager, P. A., P. H. Rees, B. T. Wellde, W. T. Hockmeyer, and W. H. Lyerly. 1981. Allopurinol in the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 75:556-559.
144. Kalter, D. C. 1994. Laboratory tests for the diagnosis and evaluation of leishmaniasis. Dermatol. Clin. 12:37-50.
145. Kar, K. 1995. Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol. 21:123-152.
146. Kemp, M., A. S. Hey, J. A. L. Kurtzhals, C. B. V. Christensen, A. Gaafar, M. D. Mustafa, A. A. Y. Kordofani, A. Ismail, A. Kharazmi, and T. G. Theander. 1994. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigotes antigens in individuals recovered from cutaneous leishmaniasis. Clin. Exp. Immunol. 96:410-415.
147. Kemp, M., J. A. L. Kurtzhals, K. Bendtzen, L. K. Poulsen, M. B. Hansen, D. K. Koech, A. Kharazmi, and T. G. Theander. 1993. Leishmania donovani-reactive Th1- and Th2-like T-cells clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun. 61:1069-1073.
148. Kohanteb, J., S. M. Ardehali, and H. K. Rezai. 1987. Detection of Leishmania donovani antigen and antibody in the urine of visceral leishmaniasis patients. Trans. R. Soc. Trop. Med. Hyg. 81:578-580.
149. Kurtzhals, J. A. L., A. S. Hey, A. Jardim, M. Kemp, K. U. Schaefer, E. O. Odera, C. B. V. Christensen, J. I. Githure, R. W. Olafson, T. G. Theander, and A. Kharazmi. 1994. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients, Clin. Exp. Immunol. 96:416-421.
150. Lafeuillade, A., P. Chaffanjon, E. Delbeque, and R. Quilichini. 1992. Maintenance itraconazole for visceral leishmaniasis in HIV infection. Am. J. Med. 92:449.
151. Laguna, F. Unpublished data.
152. Laguna, F., J. García-Samaniego, V. Moreno, and J. M. González-Lahoz. 1994. Prevalence of gastrointestinal leishmaniasis in Spanish HIV-positive patients with digestive symptoms. Am. J. Gastroenterol. 89:1606.
153. Laguna, F., J. García-Samaniego, V. Soriano, E. Valencia, C. Redondo, M. J. Alonso, and J. M. González-Lahoz. 1994. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin. Infect. Dis. 19:48-53.
154. Laguna, F., R. López-Vélez, V. Soriano, P. Montilla, J.
155. Laguna, F., J. Torre-Cisneros, V. Moreno, J. L. Villanueva, and E. Valencia. 1995. Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with HIV. Clin. Infect. Dis. 21:711-712.
156. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
157. Laskay, T., T. L. Mikó, Y. Negesse, W. Solbach, M. Röllinghoff, and D. Frommel. 1995. Detection of cutaneous Leishmania infection in paraffin-embedded skin biopsies using the polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 89:273-275.
158. Lazanas, M. C., G. A. Tsekes, S. Papandreou, N. Harhalakis, A. Scandali, E. Nikiforakis, and G. Saroglou. 1993. Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS 7:1018-1019.
159. Le Blancq, S. M. 1986. Enzymic characterization and the epidemiology of Old World Leishmania p. 333-339. In J. A. Rioux (ed.). Leishmania, taxonomie et phylogenèse. Applications éco-épidemiologiques. IMEEE, Montpellier, France.
160. Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161-259.
161. López, M., A. Gil, P. Lavilla, V. Pintado, E. Valencia, P. Martínez, and J. García-Puig. 1993. Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases. J. Antimicrob. Chemother. 32:657-659.
162. López, M., R. Inga, M. Cangalaya, J. Echevarría, A. Llanos-Cuentas, C. Orrego, and J. Arévalo. 1993. Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am. J. Trop. Med. Hyg. 49:348-356.
163. López-Vélez, R., F. Laguna, J. Alvar, J. A. Pérez-Molina, R. Molina, P. Martínez, and J. Villarrubia. 1995. Parasitic culture of buoy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J. Clin. Microbiol. 33:937-939.
164. López-Vélez, R., J. A. Pérez-Molina, C. Turrientes, L. San Miguel, and A. Guerrero. 1996. Manifestaciones clínicas y factures pronósticos de la leishmaniasis visceral en pacientes HIV+, abstr. 14/18. In VII Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
165. Lortholary, O., D. Mechali, D. Christiaens, M. Gougerot, M. Brandely, and P. Babinet. 1990. Interferon-γ associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS. Rev. Infect. Dis. 12:370-371.
166. Ma, D. D. F., A. J. Concannon, and J. Hayes. 1979. Fatal leishmaniasis in renal-transplant patient. Lancet ii:311-312.
167. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38-45.
168. Machado, E. S., M. P. Braga, A. M. Da-Cruz, S. G. Coutinho, A. R. M. Vieira, M. S. Rutowitsch, T. Cuzzi-Maya, G. Grimaldi, and J. A. Menezes. 1992. Disseminated american muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report. Mem. Inst. Oswaldo Cruz Rio J. 87:487-492.
169. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. De Carli, M. P. Piccini, R. Manetti, M. Carbonari, A. M. Pesce, G. Del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244-248.
170. Magill, A. L., M. Grögl, R. A., Gasser, W. Sun, and C. N. Oster. 1993. Visceral infetion caused by Leishmania tropica in veterans of operation Desert storm. N. Engl. J. Med. 387:1383-1387.
171. Malek Hosseini, S. A., R. Javid, H. Salahi, N. Nezakatgoo, E. Ahmad, and N. Ghahramani. 1995. A case report of kala-azar in a kidney transplant patient. Transplant. Proc. 27:2715.
172. Manson-Bahr, P. E. C., and D. R. Bell. 1987. Visceral leishmaniasis, p. 87-113. In P. E. C. Manson-Bahr and D. R. Bell (ed.). Manson's tropical diseases. 19th ed. Baillière Tindall, London, England.
173. Martínez, J. E., Alba, L. Arias, M. A. Escobar, and N. G. Saravia. 1992. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. Trans. R. Soc. Trop. Med. Hyg. 86:392-394.
174. Martínez, P., E. de la Vega, F. Laguna, V. Soriano, S. Puente, V. Moreno, M. J. Sentchordi, C. García-Aguado, and J. González-Lahoz. 1993. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 7:227-230.
175. Martínez-Fernández, R, J. D.García-Díaz, J. Gutiérrez-Sánchez, E. Riopérez-Carmena, L. Valdivieso-Varela, and F. Alonso-Navas. 1986. Leishmaniasis visceral en pacientes adictos a drogas por vía parenteral, VIH positivos. Med. Clin. 88:509-511.
176. Marty, P., J. G. Fuzibet, F. Pratlong, D. Quinsat, M. Gari-Toussaint, J. F. Dor, Y. Le Fichoux, and J. A. Rioux. 1991. Leishmaniose viscérale causée par une souche dermotrope de Leishmania infantum chez un sidéen. Bull. Soc. Pathol. Exot. 84:365-367.
177. Marty, P., Y. Le Fichoux, D. Giordana, and A. Brugnetti. 1992. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans. R. Soc. Trop. Med. Hyg. 86:249-250.
178. Marty, P., Y. Le Fichoux, F. Pratlong, and M. Gari-Toussaint. 1994. Human visceral leishmaniasis in Alpes-Maritimes. France: epidemiological characteristics for the period 1985-1992. Trans. R. Soc. Trop. Med. Hyg. 88:33-34.
179. Marty, P., I. Leger, M. Albertini, M., Gari-Toussaint, C. Tommasi, J. Manassero, Y. Le Fichoux, and R. Mariani. 1994. Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985-1992. Bull. Soc. Pathol. Exot. 87:105-109.
180. Mary, C., D. Lamouroux, S. Dunan, and M. Quilici. 1992. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-KD and 16-KD antigens for diagnosis and epidemiologic purposes. Am. J. Trop. Med. Hyg. 47:764-771.
181. Matheron, S., A. Cabié, F. Parquin C. Mayaud, P. Roux, M. Antoine, C. Chougnet, and J. P. Coulaud. 1992. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS 6:238-240.
182. McBride, M. O., M. Fisher, C. J. Skinner, R. Golden, and J. Main. 1995. An unusual gastrointestinal presentation of leishmaniasis. Scand. J. Infect. Dis. 27:297-298.
183. McBride, M. O., M. Linney, E. J. Claydon, and J. N. Weber. 1994. Visceral leishmaniasis following treatment with liposomal amphotericin B. Clin. Infect. Dis. 19:362.
184. McGhee, R. B., and W. B. Cosgrove. 1980. Biology and Physiology of the lower trypanosomatidae. Microbiol. Rev. 44:140-173.
185. Mebrahtu, Y. B., L. D. Hendricks, C. N. Oster, P. G. Lawyer, P. V. Perkins, H. Pamba, D. Koech, and C. R. Roberts. 1993. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am. J. Trop. Med. Hyg. 48:530-535.
186. Mehrathu, Y. B., P. G., Lawyer, H. Pamba, D. Koech, P. V. Perkins, C. R. Roberts, J. B. Were, and L. D. Hendricks. 1992. Biochemical characterization and zymodeme classification of Leishmania isolates from patients, vectors, and reservoir hosts in Kenya. Am. J. Trop. Med. Hyg. 47:852-892.
187. Mediavilla, J. D., M. Omar, J. Jiménez-Alonso, C. Miranda, and L. Aliaga. 1995. Leishmaniasis visceral con afectación de intestino delgado y colon en un enfermo con infección por HIV. Enferm. Infect. Microbiol. Clin. 13: 377-378.
188. Medrano, F. J., C. Cañavate, M. Leal, C. Rey, E. Lissen, and J. Alvar. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients co-infected with HIV-1. Am. J. Trop. Med. Hyg., in press.
189. Medrano, F. J., J. Hernández-Quero, E. Jiménez, J. A. Pineda, A. Rivero, A. Sánchez-Quijano, I. D. Vélez, P. Viciana, R. Castillo, M. J. Reyes, F. Carvajal, M. Leal, and E. Lissen. 1992. Visceral leishmaniasis in HIV-infected individuals: a common opportunistic infection in Spain? AIDS 6:1499-1503.
190. Medrano, F. J., E. Jiménez-Mejías, E. Calderón, C. Regordán, and M. Leal. 1993. An easy and quick method for the diagnosis of visceral leishmaniais in HIV-1-infected individuals. AIDS 13:1399.
191. Meller-Melloul, C., C. Farnarier, S. Dunan, B. Faugere, J. Franck, C. Mary, P. Bongrand, M. Quilici, and S. Kaplanski. 1991. Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients. Parasite Immunol. 13:531-536.
192. Mendonça, S. C. F., P. M. de Luca, W. Mayrink, T. G. Restom, F. Conceiçao-Silva, A. M. Da-Cruz, A. L. Bertho, C. A. Da Costa, O. Genaro, V. P. C. P. Toledo, and S. G. Coutinho. 1995. Characterization of human T-lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Am. J. Trop. Med. Hyg. 53:195-201.
193. Meredith, S. E. O., E. E. Zijlstra, G. J. Schoone, C. Kroon, G. J. J. M. Van Eys, K. U. Schaefer, A. M. El-Hassan, and P. G. Lawyer. 1993. Development and application of the polymerase chain reaction for the detection and identification of Leishmania parasites in clinical material. Arch. Inst. Pasteur 70:419-431.
194. Michaels, J. F., R. A. Monteil, P. Hofman, C. Perrin, J. G. Fucibet, Y. Le Fichoux, and R. Loubiere. 1994. Oral leishmaniasis and Kaposi's sarcoma in an AIDS patient. J. Oral Pathol. Med. 23:45-46.
195. Miralles, E. S., M. Núñez, Y. Hilara, A. Harto, R. Moreno, and A. Ledo. 1994. Mucocutaneous leishmaniasis and HIV. Dermatology 189:275-277.
196. Miralles, G. D., M. Y. Stoeckle, D. F. McDermott, F. D. Finkelman, and H. W. Murray. 1994. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62:1058-1063.
197. Miralles, P., S. Moreno, M. Pérez-Tascón, J. Cosín, M. D. Díaz, and E. Bouza. 1995. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 20:872-875.
198. Mishra, M., U. K. Biswas, D. N. Jha, and A. B. Khan. 1992. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 340:1256-1257.
199. Mishra, M., U. K. Biswas, A. M. Jha, and A. B. Khan. 1994. Amphotericin versus sodium stibogluconate in the first-line treatment of Indian kala-azar. Lancet 344:1599-1600.
200. Molina, R., J. M. Lohse, F. Pulido, F. Laguna, R. López-Vélez, and J. Alvar. Leishmania infantum in HIV co-infected patients: the additional role of sandflies in the anthroponotic cycle. Submitted for publication.
201. Molina, R., and J. Alvar. 1996. A simple protocol for the indirect xenodiagnosis of Leishmania infantum in the blood of HIV-infected patients. Ann. Trop. Med. Parasitol. 6:639-640.
202. Molina, R., C. Cañavate, E. Cercenado, F. Laguna, R. López-Vélez, and J. Alvar. 1994. Indirect xenodiagnosis of visceral leishmaniasis in ten patients with HIV-infection using colonized Phlebotomus perniciosus. AIDS 8:277-279.
203. Molina, R., R. López-Vélez, B. Gutiérrez-Solar, M. I. Jiménez, and J. Alvar. 1992. Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies. Trans. R. Soc. Trop. Med. Hyg. 86:516.
204. Mondain-Miton, V., M. Toussaint-Gari, P. Hofman, P. Marty, M. Carles, F. De Salvados, F. Miton, Y. Le Fichoux, and P. Dellamonica. 1995. Atypical leishmaniasis in a patient infected with human immunodeficiecy virus. Clin. Infect. Dis. 21:663-665.
205. Montalbán, C., J. L. Calleja, A. Erice, F. Laguna, B. Clotet, D. Podzamczer, J. Cobo, J. Mallolas, M. Yebra, A. Gallego, and the Co-operative Group for the Study of Leishmaniasis and AIDS. 1990. Visceral leishmanisis in patients infected with human immunodeficiency virus. J. Infect. 21:261-270.
206. Montalbán, C., R. Martínez-Fernández, J. L. Calleja, J. D. García-Díaz, R. Rubio, F. Dronda, S. Moreno, M. Yebra, C. Barros, J. Cobo, M. C. Martínez, F. Ruiz, and J. Costa. 1989. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev. Infect. Dis. 11:655-660.
207. Mora, A., M. Borrell, J. Galofré, and J. M. Grau. 1990. Alopurinol en el tratamiento de pacientes infectados por el VIH con leishmaniasis visceral. Enferm. Infect. Microbiol. Clin. 8:257-258.
208. Moreno, G., J. A. Rioux, G. Lanotte, F. Pratlong, and E. Serres. 1986. Le complexe Leishmania donovani s.l. analyse enzymatique et traitement numérique. Individualization du complexe Leishmania infantum. Corollaires biogéographiques et phylétiques. A propos de 146 souches originaires de l'Ancien et du Nouveau Monde, p. 105-117. In J. A. Rioux (ed.), Leishmania, taxonomie et phylogenèse. Applications éco-épidemiologiques. IMEEE, Montpellier, France.
209. Moreno, J., C. Cañavate, F. Laguna, and J. Alvar. Humoral and cellular immune responses in patients co-infected with HIV and Leishmania infantum. Submitted for publication.
210. Mosier, D., and H. Sieburg. 1994. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today 15:332-339.
211. Muigai, R., D. G. Gatei, S. Shaunak, A. Wozniak, and A. D. M. Bryceson. 1983. Jejunal function and pathology in visceral leishmaniasis. Lancet ii: 476-479.
212. Murray, H. W., A. M. Granger, and S. K. Mohanty. 1991. Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-γ and interleukin-2-independent. J. Infect. Dis. 163:622-624.
213. Murray, H. W., J. Hariprashad, and R. E. Fichtl. 1993. Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine. Antimicrob. Agents Chemother. 37:1504-1509.
214. Murray, H. W., M. J. Oca, A. M. Granger, and R. D. Schreiber. 1989. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. J. Clin. Invest. 83:1253-1257.
215. Navin, T. R., F. E. Arana, A. M. de Mérida, B. A. Arana, A. L. Castillo, and D. N. Silvers. 1990. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am. J. Trop. Med. Hyg. 42:36-42.
216. Nuzum, E., F. White III, C. Thakur, R. Dietze, J. Wages, M. Grögl, and J. Herman. 1995. Diagnosis of symptomatic visceral leishmaniais by use of the polymerase chain reaction on patient blood. J. Infect. Dis. 171:751-754.
217. Orofino, L., R. Marcen, C. Gámez, L. Orte, R. López- Vélez, C. Quereda, and J. Ortuño. 1992. Visceral leishmaniasis in renal transplant patients. Nephrol. Dial. Transplant. 7:651.
218. Palatnik de Sousa, C. B., E. Paraguai de Sousa, E. M. Gomes, F. C. Soares Machado, M. F. Melo, J. M. Telles da Cunha, K. G. Luz, and R. Borojevic. 1995. Transmission of visceral leishmaniasis by blood transfusion in hamsters. Mem. Inst. Oswaldo Cruz 90(Suppl. 1):189.
219. Pampligione, S., P. E. C. Manson Bahr, F. Glungi, G. Giunti, A. Parenti, and G. Canestri Trotti. 1974. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 68:447-453.
220. Pampiglione, S., P. E. C. Manson-Bahr, M. La-Placa, M. A. Borgatti, and F. Micheloni. 1976. Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 70:62-65.
221. Pampiglione, S., P. E. C. Manson-Bahr, M. La-Placa, M. A. Borgatti, and S. Musumeci. 1975. Studies on Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans. R. Soc. Trop. Med. Hyg. 69:60-68.
222. Perea, W. A., T. Ancelle, A. Moren, M. Nalgelkerke, and E. Sundorp. 1991. Visceral leishmaniasis in Southern Sudan. Trans. R. Soc. Trop. Med. Hyg. 85:48-53.
223. Perelló-Roso, A., J. López-Aldeguer, P. Garcia-Gascó, and M. Blanes. 1996. Polyarthritis caused by Leishmania in a patient with AIDS. Clin. Infect. Dis. 22:1113-1114.
224. Pérez-Molina, J. A., R. López-Vélez, P. Montilla, and A. Guerrero. 1996. Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 10:237-238.
225. Peters, B. S., D. Fish, R. Golden, D. A. Evans, A. D. M. Bryceson, and A. J. Pinching. 1990. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q. J. Med. New Ser. 283:1101-1111.
226. Pharoah, P. D. P., J. M. Ponnighaus, D. Chavula, and S. B. Lucas. 1993. Two cases of cutaneous leishmaniasis in Malawi. Trans. R. Soc. Trop. Med. Hyg. 87:668-670.
227. Pialoux, G., C. Hennequin, B. Dupont, and P. Ravisse. 1990. Cutaneous leishmaniasis in an AIDS patient: cure with itraconazole. J. Infect. Dis. 162:1221-1222.
228. Piarroux, R., F. Gambarelli, H. Dumon, M. Fontes, S. Dunan, C. Mary, B. Toga, and M. Quilici. 1994. Comparision of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniais in immunocompromised patients. J. Clin. Microbiol. 32:746-749.
229. Piarroux, R., F. Gambarelli, B. Toga, H. Dumon, M. Fontes, S. Dunan, and M. Quilici. 1996. Interest and reliability of a polymerase chain reaction on bone marrow samples in the diagnosis of visceral leishmaniasis in AIDS. AIDS 10:452-453.
230. Pineda, J. A., J. Hernández-Quero, J. A. Gallardo, M. A. López-Ruz, M. A. Martínez-Pérez, J. Macías, and E. Lissen. 1996. Frequency of suhclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 15:263-264.
231. Pittaluga, G. 1926. Estudio epidemiológico de la "leishmaniosis visceral" en España. Rev. Méd. Barcelona 5:42-62.
232. Portús, M., M. Gállego, J. A. Rioux, F. Pratlong, G. Moreno, R. Fisa, M. Gállego, C. Muñoz, C. Riera, F. Sánchez, and T. Serra. 1989. Enzymatic heterogeneity among strains of Leishmania infantum from human visceral and cutaneous leishmaniosis in Catalonia (Spain). Rev. Ibér. Parasitol. 49:287-289.
233. Pratlong, F., J. P. Dedet, P. Marty, M. Portús, M. Deniau, J. Dereure, P. Abranches, J. Reynes, A. Martini, M. Lefebvre, and J. A. Rioux. 1995. Leishmania-human innmmunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J. Infect. Dis. 172:323-326.
234. Pratlong, F., J. Reynes, J. Dereure, M. T. Baixench, B. Marchou, M. Lefebvre, and F. Janbon. 1993. Characterization of Leishmania isolates from two AIDS patients originating from Valencia, Spain. Trans. R. Soc. Trop. Med. Hyg. 87:705-706.
235. Pulido, F., R. Rubio, and J. R. Costa. 1995. Visceral Leishmaniasis as a cause of diarrhoea in HIV-infected patients. AIDS 9:661-662.
236. Qu, J. Q., L. Zhong, M. Massom-Yasinzai, M. Abdur-Rab, H. S. Z. Aksu, S. G. Reed, K. P. Chang, and A. Gilman-Sachs. 1994. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans. R. Soc. Trop. Med. Hyg. 88:543-545.
237. Rab, M. A., and D. A. Evans. 1995. Leishmania infantum in the Himalayas. Trans. R. Soc. Trop. Med. Hyg. 89:27-32.
238. Rab, M. A., M. Hassan, D. Bux, M. T. Mahmood, and D. A. Evans. 1992. The isolation and cultivation of Leishmania infantum from apparently normal skin of visceral leishmaniasis patients in northern Pakistan. Trans. R. Soc. Trop. Med. Hyg. 86:620-621.
239. Raffi, F., D. Merrien, P. Le Pape, and V. Reliquet 1995. Use of itraconazole allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clin. Infect. Dis. 21:1338-1339.
240. Rajendran, P., S. N. Chatterjee, and J. B. O. Gupta. 1989. Observations on human bone-marrow for Leishmania donovani. Indian J. Pathol. Microbiol. 32:282-285.
241. Ravel, S., G. Cuny, J. Reynes, and F. Veas. 1995. A hyghly sensitive and rapid procedure for direct detection of Leishmania infantum within human peripheral blood mononuclear cells. Acta Trop. 59:187-196.
242. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
243. Ribera, E., E. Cucurrull, I. Ocaña, T. Vallespí, I. Gasser, and C. Juste. 1995. Leishmaniasis visceral en pacientes con infección por HIV. Enferm. Infect. Microbiol. Clin. 13:73-79.
244. Ribera, E., I. Ocaña, J. Otero, E. Cortes, I. Gasser, and A. Pahissa. 1996. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am. J. Med. 100:496-501.
245. Riera, C., S. Torras, M. Gállego, R. Fisa, F. Pratlong, M. Colmenares, M. J. Aisa, A. Martini, M. Portús, and Grupo Catalán para el Estudio de la Leishmaniasis. 1994. Estudio de la asociación VIH-Leishmania en Cataluña durante el periodo 1990-1994 a través de los datos recogidos por el Grupo Catalán para el Estudio de la Leishmaniasis, abstr. p. 9. In X Reunión Anual de la Asociación de Parasitólogos Españoles. Sitges, Barcelona, Spain.
246. Rioux, J. A., G. Moreno, G. Lanotte, F. Pratlong, J. Dereure, and P. Rispail. 1986. Two episodes of cutaneous leishmaniasis in man caused by different zymodemes of Leishmania infantum s.l. Trans. R. Soc. Trop. Med. Hyg. 80:1004-1005.
247. Rioux, J. A., G. Lanotte, E. Serres, F. Pratlong, P. Bastien, and J. Perieres. 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann. Parasitol. Hum. Comp. 65:111-125.
248. Rocha, A., A. C. Oliveira de Meneses, A. Moreira da Silva, M. S. Ferreira, S. A. Nishioka, M. K. N. Burgarelli, E. Almeida, G. Turcato, K. Metze, and E. R. Lopes. 1994. Pathology of patients with Chagas disease and adquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 50:261-268.
249. Rodrigues-Coura, J., B. Galvâo-Castro, and G. Grimaldi. 1987. Disseminated American cutaneous leishmaniasis in a patient with AIDS. Mem. Ins. Oswaldo Cruz Rio J. 82:581-582.
250. Rodríguez, N., B. Guzmán, A. Rodas, H. Takiff, B. R. Bloom, and J. Convit. 1994. Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J. Clin. Microbiol. 32:2246-2252.
251. Roig, P., J. M. Cuadrado, C. Benitez, M. J. Mayol, M. López, V. Navarro, A. Nieto, and B. Bernacer. 1993. Leishmaniasis visceral de localizacion intestinal en pacientes con infección por el virus de la inmunodeficiencia humana: presentación de dos casos. Rev. Clin. Esp. 192:271-273.
252. Romeu J., F. Milla, M. Batlle, G. Sirera, C. Ferrandiz, A. Carreres, M. J. Condom, and B. Clotet. 1991. Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion. AIDS 5:1272.
253. Rosenthal, E., P. Marty, and A. Pesce. 1991. Leishmania in bronchoalveolar lavage. Ann. Intern. Med. 114:1064-1065.
254. Rosenthal, E., P. Marty, I. Poizot-Martín, J. Reynes, F. Pratlong, A. Lafeuillade, D. Jaubert, O. Boulat, J. Dereure, F. Gambarelli, J.-A. Gastaut, P. Dujardin, P. Dellamonica, and J. P. Cassuto. 1995. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans. R. Soc. Trop. Med. Hyg. 89:159-162.
255. Rosenthal, P. J., R. E. Chaisson, W. K. Hadley, and J. H. Leech. 1988. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome. Am. J. Med. 84:307-309.
256. Sabbatani, S., A. Isquierdo Calzado, A. Ferro, A. M. López Goudlaby, V. Borghi, G. P. Zanchetta, and O. E. Vannier. 1991. Atypical leishmaniais in an HIV-2-seropositive patient from Guinea-Bissau. AIDS 5:899-900.
257. Sacramento, R., A. Horta, O. Vasconcelos, H. Coelho, C. Granato, and A. Rocha. 1995. Leishmaniasis visceral en enfermo infectado por VIH-2. Rev. Clin. Esp. 195:591-592.
258. Salinas, G., L. Valderrama, G. Palma, G. Montes, and N. G. Saravia. 1990. Detection of amastigotes in cutaneous and mucocutaneous leishmaniasis using immunoperoxidase method, using policlonal antibodies: sensitivity and specificty compared with conventional methods of diagnosis. Mem. Inst. Oswaldo Cruz Rio J. 84:56-60.
259. Sanz, M., R. Rubio, A. Casillas, C. Guijarro, J. R. Costa, R. Martínez, and J. de Dios-García. 1991. Visceral leishmaniasis in HIV-infected patients. AIDS 5:1272-1274.
260. Saran, R., and A. K. Gupta. 1988. Supplemented Schneider's Drosophila medium for isolation of Leishmania donovani promastigotes. Ann. Trop. Med. Parasitol. 82:403-404.
261. Saran, R., A. K. Gupta, and L. S. N. Prasad. 1988. A search for Leishmania in normal skin and blood of kala-azar patients from Bihar, India. J. Commun. Dis. 20:89-90.
262. Saravia, N. G., K. Weigle, I. Segura, S. H. Gianini, R. Pacheco, L. A. Labrada, and A. Goncalves. 1990. Recurrent lesions in the human Leishmania braziliensis infection: reactivation or reinfection?. Lancet 336:398-402.
263. Scaglia, M., A. Malfitano, H. Douville, P. Sacchi, S. Gatti, L. Gradoni, and M. Gramiccia. 1996. Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin. Infect. Dis. 22:376-377.
264. Scaglia, M., M. Villa, S. Gatti, and F. Fabio. 1989. Cutaneous leishmaniasis in acquired immunodeficiency syndrome. Trans. R. Soc. Trop. Med. Hyg. 83:338-339.
265. Schaefer, K. U., G. J. Schoone, G. S. Gachihi, A. S. Müller, P. A. Kager, and S. E. O. Meredith. 1995. Visceral leishmaniais: use of the polymerase chain reaction in an epidemiological study in Baringo District. Kenya. Trans. R. Soc. Trop. Med. Hyg. 83:492-495.
266. Schirilo, G., A. Russo, S. Musumeci, and A. Sciotto. 1978. Visceral leishmaniasis following a skin lesion in a six-years-old Sicilian girl. Trans. R. Soc. Trop. Med. Hyg. 72:656-657.
267. Scott, J. A. G., R. N. Davidson, A. H. Moody, H. R. Grant, D. Felmingham, G. M. S. Scott, P. Olliaro, and A. D. M. Bryceson. 1992. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into United Kingdom. Trans. R. Soc. Trop. Med. Hyg. 86:617-619.
268. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149-3155.
269. Seaman, J., C. Boer, R. Wilkinson, J. Jong, E. Wilde, E. Sondorp, and R. N. Davidson. 1995. Liposomal amphotericine B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin. Infect. Dis. 21:188-193.
270. Seaman, J., D. Pryce, H. E. Sondorp, A. Moody, A. D. M. Bryceson, and R. N. Davidson. 1993. Epidemic visceral leishmaniasis in Sudan: a randomized trial of Aminosidine plus sodium stibogluconate alone. J. Infect. Dis. 168:715-720.
271. Sendino, A., F. J. Bragado, J. M. Mostaza, J. Fernández-Martín, J. Larrauri, and J. J. Vázquez-Rodríguez. 1990. Visceral leishmaniasis with malabsorption syndrome in a patient with acquired immunodeficiency syndrome. Am. J. Med. 89:673-675.
272. Serra, T., J. P. Dedet, F. Pratlong, A. Ramírez, E. Arteaga, J. Altés, J. Gállego, J. Sánchez, and Grupo para el Estudio de la Leishmaniasis Balear. 1994. Caracterización isoenzimática de cepas de Leishmania aisladas en las islas Baleares, abstr. p. 11. In X Reunión Anual de la Asociación de Parasitólogos Españoles, Sitges, Barcelona, Spain.
273. Sharma, M. C., A. K. Gupta, R. Saran, and S. P. Sinha. 1990. The effect of age and sex on incidence of kala azar. J. Commmun. Dis. 22:277-278.
274. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21-24.
275. Sherwood, J. A., G. S. Gachihi, R. K. Muigai, D. R. Skillman, M. Mugo, J. R. Rashid, K. M. A. Wasunna, J. B. O. Were, S. K. Kasili, J. M. Mbugua, G. Kirigi, K. U. Schaefer, C. N. Oster, L. L. Fleckenstein, J. D. Berman, T. D. Berman, T. G. Brewer, C. R. Roberts, A. J. Johnson, and B. G. Schuster. 1994. Phase 2 efficacy-trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin. Infect. Dis. 19:1034-1039.
276. Siddig, M., H. Ghalib, D. C. Shillington, and E. A. Petersen. 1988. Visceral leishmaniasis in the Sudan: comparative methods of diagnosis. Trans. R. Soc. Trop. Med. Hyg. 82:66-68.
277. Sinha, R., U. Datta, and S. Sehgal. 1993. Importance of bone marrow culture for diagnosis of kala azar. Scand. J. Infect. Dis. 25:787-789.
278. Smith, D., B. Gazzard, R. P. Lindley, A. Darwash, C. Reed, A. D. M. Bryceson, and D. A. Evans. 1989. Visceral leishmaniasis (kala-azar) in a patient with AIDS. AIDS 3:41-43.
279. Smyth, A. J., A. Ghosh, Md. Q. Hassan, D. Basu, M. H. L. De Bruijn, S. Adhya, K. K. Mallik, and D. C. Barker. 1992. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients. Parasitology 105:183-192.
280. Squires, K. E., F. Rosenkaimer, J. A. Sherwood, A. L. Forni, J. B. O. Were, and H. W. Murray. 1993. Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. Am. J. Trop. Med. Hyg. 48:666-669.
281. Sundar, S., K. Kumar, and V. P. Singh. 1990. Ketoconazole in visceral leishmaniasis. Lancet 336:1582-1583.
282. Sundar, S., V. P. Singh, and H. W. Murray. 1995. Successful short course liposomal amphotericin B therapy in refractory Indian visceral leishmaniasis. abstr. 483. In XIXth International Congress of Chemotherapy.
283. Sylva, J. S., M. Barral-Netto, and S. G. Reed. 1993. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections. Am. J. Trop. Med. Hyg. 49:589-597.
284. Taillan, B., P. Marty, S. Schneider, H. Telle, J. G. Fuzibet, E. Rosenthal, A. Rahal, Y. Le Fichoux, and P. Dujardin. 1992. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin. Eur. J. Intern. Med. 1:255.
285. Tata, M., A. Kumar, and H. Feiner. 1993. Visceral leishmaniasis in the acquired immunodeficiency syndrome: report of two cases. Hum. Pathol. 24:1379-1381.
286. Thakur, C. P., M. Kumar, and A. K. Pandey. 1991. Comparison of regimens of treatment of antimony resistant kala azar patients: a randomized study. Am. J. Trop. Med. Hyg. 45:435-441.
287. Thakur, C. P., P. Olliaro, S. Gothoskar, S. Bhowmick, B. K. Choudhury, S. Prasad, M. Kumar, and B. B. Verma. 1992. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 86:615-616.
288. Theodor, O. 1964. Leishmaniases, p. 475-493. In J. van der Hoeden (ed.), Zoonoses. Elsevier Publishing Co., Amsterdam, The Netherlands.
289. Tieszen, K. L., and D. H. Molyneux. 1989. Transmission and ecology of trypanosomatid flagellates of water striders (Hemiptera: Gerridae). J. Protozool. 36:519-523.
290. Torre-Cisneros, J., J. L. Villanueva, J. M. Kindelán, R. Jurado, and P. Sánchez-Guijo. 1993. Succesful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:625-627.
291. Tremblay, M., M. Olivier, and R. Bernier. 1996. Leishmania and the pathogenesis of HIV infection. Parasitol. Today 12:257-261.
292. Van Voorhis, W. C. 1990. Therapy and prophylaxis of systemic protozoan infections. Drugs 40:176-202.
293. Veiga, J. R., E. R. Wolff, R. N. Sampaio, and P. D. Marsden. 1983. Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials. Lancet ii:5693.
294. Villanueva, J. L., J. Torre-Cisneros, R. Jurado, A. Villar, M. Montero, F. López, P. Sánchez-Guijo, and J. M. Kindelán. 1994. Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. Am. J. Gastroenterol. 89:273-275.
295. Wali, J. P., P. Aggarwal, U. Gupta, S. Saluja, and S. Singh. 1990. Ketoconazole in treatment of visceral leishmaniasis. Lancet 336:810-811.
296. Ward, R. D., R. Lainson, and J. J. Shaw. 1978. Some methods for membrane feeding of laboratory reared neotropical sandflies (Diptera: Psychodidae). Ann. Trop. Med. Parasitol. 72:269-276.
297. Weigle, K. A., M. de Dávalos, P. Heredia, R. Molineros, N. G. Saravia, and A. D'Alessandro. 1987. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am. J. Trop. Med. Hyg. 36:489-496.
298. Wong, B., J. W. M. Gold, A. E. Brown, M. Lange, R. Fried, M. Grieco, D. Mildvan, J. Giron, M. L. Tapper, C. W. Lerner, and D. Armstrong. 1984. Central nervous system toxoploplasmosis in homosexual men and parenteral drug abusers. Ann. Intern. Med. 100:36-42.
299. World Health Organization. 1990. Control of the leishmaniases. Expert Commitee. W. H. O. Tech. Rep. Ser. 793:27.
300. World Health Organization. 1984. Leishmaniases. Expert Commitee. W. H. O. Tech. Rep. Ser. 701:111.
301. World Health Organization. 1995. Report on the consultative meeting on Leishmania/HIV co-infection. WHO/LEISH/95.35, p. 1-14. World Health Organization, Geneva, Switzerland.
302. Yebra, M., J. Segovia, L. Manzano, J. A. Vargas, L. Bernaldo de Quirós, and J. Alvar. 1988. Disseminated-to-skin kala-azar and the aquired immunodeficiency syndrome. Ann. Intern. Med. 108:490-491.
303. Zijlstra, E. E., M. Siddig Ali, A. M. El-Hassan, I. A. El-Toum, M. Satti, H. W. Ghalib, and P. A. Kager. 1992. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans. R. Soc. Trop. Med. Hyg. 86:505-507.
304. Zwingenberger, K., H. Gundel, C. Pedrosa, S. Omena, B. Sandkamp, and S. Neifer. 1990. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clin. Immunol. Immunopathol. 57:242-249.